Fasting insulin — lab reference
Some search terms matchedNo universal reference or treatment target. Standardize fasting duration and collection time.
THE PURSER WELLNESS ENCYCLOPEDIA
639 resources for your curiosity57 matching listings grouped; alternative sources stay available.
What’s searchable?No universal reference or treatment target. Standardize fasting duration and collection time.
Ask your clinician to read this result with concurrent glucose, kidney function, and exogenous insulin use.
Formula-dependent and population-dependent. Dr. Purser to define clinic interpretation, if used.
Assay-specific; reflects approximately 2-3 weeks and is affected by protein turnover.
Fasting, ketogenic diets, illness, and diabetes context materially affect interpretation.
Screening measure, not a stand-alone treatment target.
Risk-based goals may be <100, <70, or <55 depending on primary/secondary prevention risk.
Higher HDL is not always protective; interpret within the entire risk profile.
150-199 borderline high; 200-499 high; ≥500 severe and pancreatitis-relevant.
Risk-based goals may be lower; useful when triglycerides are elevated.
Often calculated. Less reliable when triglycerides are markedly elevated.
90-99 above desirable; 100-119 borderline high; 120-139 high; ≥140 very high. Risk goals may be lower.
Search looks for your words in titles, descriptions, available articles, learning guides, and video captions when available. The closest matches appear first. Duplicate posts are grouped, with links to other places you can read or watch them. Books, chapters, and reports have topic guides here; the original files and full book text are not available in this encyclopedia. Subscriber posts include a title and public summary; open Substack to read the full post.